Cionic Neural Sleeve received FDA authorization in March 2022 for functional electrical stimulation to aid with locomotion ...

Percutaneous electrical stimulation is effective in reducing chronic knee pain and improving functionality in affected patients.

A novel method of electrical stimulation to precisely control neural activity for sensory restoration exhibits improvements in visual stimulus reconstruction, enables efficient hardware design, and ...

NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...

Stim, which expands the IB-Stim addressable market by roughly 75%,” said Brian Carrico, President and Chief Executive Officer of NeurAxis. “Furthermore, we expect devices per patient to increase, as ...

Category I code for Percutaneous Electrical Nerve Field Stimulation (PENFS) procedures effective January 1, 2026. NeurAxis’ PENFS technology, IB-Stim, is FDA-cleared for functional abdominal ...

This two-in-one strategy turns out to leverage the benefits of both tissue transplantation and electrical stimulation in enhancing neural regeneration and functional recovery. The scientists from ...